Ganesh Benzoplast FY26 net profit rises 93% to ₹733.36 million

Ganesh Benzoplast reported its audited consolidated financial results for the year ended March 31, 2026, recording a net profit of ₹733.36 million, a significant increase from ₹380.86 million in the previous year. The company’s revenue from operations for FY26 stood at ₹4,114.19 million, compared to ₹3,743.11 million in FY25, driven by growth across its LST and Chemical divisions. For the quarter ended March 31, 2026, the company posted a consolidated net profit of ₹152.94 million, reversing the net loss of ₹131.92 million reported in the corresponding quarter of the previous year.

Financial Performance

The board approved the standalone and consolidated audited financial results on May 27, 2026. Revenue for Q4FY26 increased to ₹1,114.70 million from ₹999.34 million in Q4FY25. The statutory auditors, M/s. Mittal & Associates, issued an unmodified opinion on the standalone and consolidated financial results.

The following table summarizes the key consolidated financial metrics for FY26:

Metric:	FY26 (Audited)	FY25 (Audited)
Revenue from Operations:	₹4,114.19 million	₹3,743.11 million
Total Income:	₹4,368.57 million	₹3,920.04 million
Profit Before Tax:	₹980.15 million	₹519.22 million
Net Profit:	₹733.36 million	₹380.86 million
Earnings Per Share (Basic):	₹10.19	₹5.29

Segment Performance

The LST Division reported segment revenue of ₹2,258.73 million for FY26, up from ₹2,004.81 million in the prior year. The Chemical Division recorded revenue of ₹1,855.45 million, compared to ₹1,738.30 million in FY25. Total segment assets for the group stood at ₹7,183.20 million as of March 31, 2026.

Corporate Governance and Auditors

The board appointed M/s S.K Agarwal & Associates, Cost Accountants, as the Cost Auditors for FY 2026-27. Additionally, M/s. V K Baheti & Co., Chartered Accountants, were appointed as Internal Auditors for the financial year 2026-27.

Strategic Initiatives

The board initiated the process to form a wholly-owned subsidiary company in Singapore to explore future business opportunities and promote business development in the region. The formation is subject to compliance with applicable statutory and regulatory requirements in India and Singapore.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-3.10%	-4.42%	-6.18%	+13.71%	-16.02%	+1.88%

Anil Kumar Dedhia has disposed of 8,50,000 shares of ganesh benzoplast via an open market transaction on May 20, 2026. The sale was disclosed to the stock exchanges under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Following the sale, the total equity share capital of the company remains unchanged at 7,19,89,421 shares of Re 1 each.

Prior to the transaction, Anil Kumar Dedhia held 33,36,000 shares, which accounted for 4.63% of the company's total paid-up share capital. The disposal of 8,50,000 shares, representing 1.18% of the capital, has reduced his stake to 24,86,000 shares. This revised holding constitutes 3.45% of the total voting capital of the company.

Shareholding Details

The disclosure outlines the shift in shareholding percentages for the acquirer and Persons Acting in Concert (PAC). The table below details the holdings before and after the transaction.

Name	Shareholding Before	% Before	Acquisition/Sale	Shareholding After	% After
Anil Kumar Dedhia	3336000	4.63	8,50,000	2486000	3.45
Sandhya Anil Dedhia	525000	0.73	0	525000	0.73
Anil V Dedhia (HUF)	95000	0.14	0	95000	0.14
Vasanji Shamji Dedhia (HUF)	45000	0.06	0	45000	0.06
Total	40,01,000	5.56		31,51,000	4.38

Transaction Overview

The transaction was executed exclusively through the open market mechanism. The seller does not belong to the promoter or promoter group of the company. The total diluted share capital of Ganesh Benzoplast Limited remains at 7,19,89,421 equity shares following the transaction. The shares of the company are listed on both the BSE Limited and the National Stock Exchange of India Limited.